BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38324963)

  • 1. Clear-cell papillary renal cell tumour: New insights into clinicopathological features and molecular landscape after renaming by 5th WHO classification.
    Zhang W; Zhang L; Wen Z; Liang J; Wang Y; Wang Z; Yin Z; Fan L
    Pathol Res Pract; 2024 Mar; 255():155167. PubMed ID: 38324963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology.
    Lin X
    Cytopathology; 2024 May; ():. PubMed ID: 38751143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Sarcomatoid Renal Cell Carcinoma with Clear Cell Papillary-Like Primary Tumor and Lymph Node Metastasis: A Diagnostic Conundrum.
    Demko N; Glennon KI; Arseneault M; Lach K; Nishimura T; Tanguay S; Riazalhosseini Y; Brimo F
    Int J Surg Pathol; 2023 Aug; 31(5):890-895. PubMed ID: 36562104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
    Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
    Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.
    Weng S; DiNatale RG; Silagy A; Mano R; Attalla K; Kashani M; Weiss K; Benfante NE; Winer AG; Coleman JA; Reuter VE; Russo P; Reznik E; Tickoo SK; Hakimi AA
    Eur Urol; 2021 Apr; 79(4):468-477. PubMed ID: 33046271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological and molecular genetic characteristics of ELOC mutated renal cell carcinoma].
    Wen Z; Zhang WH; Liang JY; Chai J; Wang YM; Xu WN; Wang Z; Fan LN
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1204-1209. PubMed ID: 38058035
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
    Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
    Griffin BB; Lin X
    Cancer Cytopathol; 2021 Mar; 129(3):192-203. PubMed ID: 33036062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic features and differential diagnosis of multilocular cystic renal cell carcinoma].
    Zhang W; Li Y; Lu Q; Zhuang J; Wang Q; Zhao H; Yu W; Kang E; Feng Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):723-7. PubMed ID: 25582248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease.
    Chan E; Stohr BA; Butler RS; Cox RM; Myles JL; Nguyen JK; Przybycin CG; Reynolds JP; Williamson SR; McKenney JK
    Am J Surg Pathol; 2022 Mar; 46(3):392-403. PubMed ID: 34881751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological and prognostic characteristics of clear cell papillary renal cell carcinoma].
    Xu YW; Zhou JC; Xie HB; Yang WP; Li L; Zhang KN; Ma KF; Gong YQ; Zhang Z; Cai L; Gong K
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3784-3788. PubMed ID: 34895417
    [No Abstract]   [Full Text] [Related]  

  • 16. Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.
    Liu K; Ren Y; Pang L; Qi Y; Jia W; Tao L; Hu Z; Zhao J; Zhang H; Li L; Yue H; Han J; Liang W; Hu J; Zou H; Yuan X; Li F
    Int J Clin Exp Pathol; 2015; 8(7):8311-35. PubMed ID: 26339402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
    Tian X; Xu WH; Wu JL; Gan HL; Wang HK; Gu WJ; Qu YY; Zhang HL; Ye DW
    Pathol Oncol Res; 2021; 27():1609809. PubMed ID: 34512202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
    Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
    Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases.
    Tjota MY; Sharma A; Wanjari P; Fitzpatrick C; Segal J; Antic T
    Hum Pathol; 2023 Apr; 134():124-133. PubMed ID: 36592877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytopathologic features of clear cell papillary renal cell carcinoma: A recently described variant to be considered in the differential diagnosis of clear cell renal epithelial neoplasms.
    Sayeed S; Lindsey KG; Baras AS; Jackson C; Powers CN; Uram-Tuculescu C; Smith SC
    Cancer Cytopathol; 2016 Aug; 124(8):565-72. PubMed ID: 27062008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.